Mertens Ann C
Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota 55455, USA.
Pediatr Blood Cancer. 2007 Jun 15;48(7):723-6. doi: 10.1002/pbc.21114.
Survivors of childhood and adolescent cancer are at risk for long-term effects of disease and treatment. The Childhood Cancer Survivor Study assessed overall and cause-specific mortality in a retrospective cohort of 20,690 5-year survivors. Eligible subjects were individuals diagnosed with cancer (from 1970 to 1986) before the age of 21 who had survived 5 years from diagnosis. Underlying cause of death was obtained from death certificates and other sources, then and coded and categorized as recurrent disease, sequel of cancer treatment, or non-cancer-related. Age and sex standardized mortality ratios (SMRs) were calculated using United States population mortality data. The cohort demonstrated an 8.2-fold excess in overall mortality (95% confidence interval, 7.9 to 8.5). Recurrence of the original cancer was the leading cause of death among 5-year survivors, accounting for 57% of deaths. Statistically significant excess mortality rates were seen due to subsequent malignancies (SMR = 15.0), along with cardiac (SMR = 6.9), and pulmonary (SMR = 8.7). There was no increase seen for automotive accidents (SMR = 1.0), other accidents (SMR = 1.3), or suicide (SMR = 1.0). While recurrent disease remains a major contributor to late mortality in 5-year survivors of childhood cancer, significant excesses in mortality risk associated with treatment-related complications exist up to 25 years after the initial cancer diagnosis.
儿童和青少年癌症幸存者面临疾病和治疗带来的长期影响风险。儿童癌症幸存者研究评估了20690名5年幸存者的回顾性队列中的总体死亡率和特定病因死亡率。符合条件的受试者是在21岁之前被诊断患有癌症(1970年至1986年)且自诊断后存活5年的个体。死亡的根本原因从死亡证明和其他来源获取,然后进行编码并分类为复发性疾病、癌症治疗后遗症或与癌症无关。使用美国人口死亡率数据计算年龄和性别标准化死亡率(SMR)。该队列显示总体死亡率高出8.2倍(95%置信区间,7.9至8.5)。原癌复发是5年幸存者中的主要死亡原因,占死亡人数的57%。由于后续恶性肿瘤(SMR = 15.0)、心脏疾病(SMR = 6.9)和肺部疾病(SMR = 8.7),观察到具有统计学意义的过高死亡率。汽车事故(SMR = 1.0)、其他事故(SMR = 1.3)或自杀(SMR = 1.0)未见增加。虽然复发性疾病仍然是儿童癌症5年幸存者晚期死亡的主要原因,但在初始癌症诊断后长达25年,与治疗相关并发症相关的死亡风险显著过高。